Clinical Significance of ALDH2 Rs671 Polymorphism in Esophageal Cancer: Evidence from 31 Case-Control Studies

Tingting Zhao,Chun Wang,Lili Shen,Dongying Gu,Zhi Xu,Xunlei Zhang,Yong Xu,Jinfei Chen
DOI: https://doi.org/10.2147/ott.s76526
IF: 4
2015-01-01
OncoTargets and Therapy
Abstract:BACKGROUND:Aldehyde dehydrogenase 2 (ALDH2), a critical enzyme for the detoxification of alcohol, is associated with many types of cancers. To verify the relationship of ALDH2 rs671 G>A polymorphism and esophageal cancer (EC), we performed a meta-analysis of a total of 31 published data including 8,510 patients and 16,197 controls.METHODS:The pooled odds ratio (OR) and the 95% confidence interval (CI) were calculated using a fixed or random-effects model. Heterogeneity (PH ), publication bias, and sensitivity analysis were also determined.RESULTS:Although a protective effort was found in the rs671 homozygote comparison (AA/GG: OR=0.69; 95% CI=0.48-0.98), the heterozygote comparison was apparently associated with the risk of EC, particularly in the Chinese population (AG/GG:OR=1.39; 95% CI=1.03-1.87). Alcohol consumption remarkably increased this risk, especially in the AG genotype. Drinking men with the AG genotype appeared to show a higher risk (AG/GG:OR=4.39; 95% CI=1.24-6.55) than drinking women.CONCLUSION:The present meta-analysis provided advanced information regarding the association of the ALDH2 A>G polymorphism and EC. Taken together, insights from this study suggested an enhanced effect on the development of EC through a genetic-environmental interaction.
What problem does this paper attempt to address?